Thanks @avemaria and Mozzarc for that information. I didn't realise there was more information on Fiftyone capital's website regarding the barriers for others creating this drug. Their Livewiremarkets.com article certainly didn't mention those barriers. Certainly doesn't sound easy to make, this PPS stuff. PAR definitely looks like it has potential to be a 'multi-bagger'. Will keep a close eye on this one.
The Future, page-51
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 22818 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |